Curachem Statistics
Total Valuation
Curachem has a market cap or net worth of KRW 12.46 billion.
| Market Cap | 12.46B |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Curachem has 1.75 million shares outstanding.
| Current Share Class | 1.75M |
| Shares Outstanding | 1.75M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.26% |
| Float | 1.46M |
Valuation Ratios
The trailing PE ratio is 9.97.
| PE Ratio | 9.97 |
| Forward PE | n/a |
| PS Ratio | 2.07 |
| PB Ratio | 1.62 |
| P/TBV Ratio | 1.69 |
| P/FCF Ratio | 8.62 |
| P/OCF Ratio | 8.09 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.16, with a Debt / Equity ratio of 0.67.
| Current Ratio | 5.16 |
| Quick Ratio | 4.17 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 3.02 |
| Debt / FCF | 3.59 |
| Interest Coverage | 5.82 |
Financial Efficiency
Return on equity (ROE) is 15.04% and return on invested capital (ROIC) is 5.27%.
| Return on Equity (ROE) | 15.04% |
| Return on Assets (ROA) | 4.85% |
| Return on Invested Capital (ROIC) | 5.27% |
| Return on Capital Employed (ROCE) | 8.42% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.43 |
| Inventory Turnover | 3.52 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.74% in the last 52 weeks. The beta is -0.23, so Curachem's price volatility has been lower than the market average.
| Beta (5Y) | -0.23 |
| 52-Week Price Change | -57.74% |
| 50-Day Moving Average | 8,300.00 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 24.67 |
| Average Volume (20 Days) | 76 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Curachem had revenue of KRW 6.02 billion and earned 1.08 billion in profits. Earnings per share was 712.00.
| Revenue | 6.02B |
| Gross Profit | 2.93B |
| Operating Income | 1.08B |
| Pretax Income | 1.08B |
| Net Income | 1.08B |
| EBITDA | 1.72B |
| EBIT | 1.08B |
| Earnings Per Share (EPS) | 712.00 |
Balance Sheet
The company has 4.14 billion in cash and 5.19 billion in debt, giving a net cash position of -1.05 billion or -597.02 per share.
| Cash & Cash Equivalents | 4.14B |
| Total Debt | 5.19B |
| Net Cash | -1.05B |
| Net Cash Per Share | -597.02 |
| Equity (Book Value) | 7.71B |
| Book Value Per Share | 4,860.21 |
| Working Capital | 4.84B |
Cash Flow
In the last 12 months, operating cash flow was 1.54 billion and capital expenditures -94.15 million, giving a free cash flow of 1.44 billion.
| Operating Cash Flow | 1.54B |
| Capital Expenditures | -94.15M |
| Free Cash Flow | 1.44B |
| FCF Per Share | 823.44 |
Margins
Gross margin is 48.72%, with operating and profit margins of 17.89% and 17.90%.
| Gross Margin | 48.72% |
| Operating Margin | 17.89% |
| Pretax Margin | 17.90% |
| Profit Margin | 17.90% |
| EBITDA Margin | 28.50% |
| EBIT Margin | 17.89% |
| FCF Margin | 24.00% |
Dividends & Yields
Curachem does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 0.05% |
| Earnings Yield | 8.65% |
| FCF Yield | 11.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Curachem has an Altman Z-Score of 0.94 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.94 |
| Piotroski F-Score | 7 |